Allos Therapeutics is a pharmaceutical company focused on developing andcommercializing innovative small molecule drugs, initially for improving cancer treatments. The company''s lead product candidate is RSR13. RSR13 is a synthetic small molecule that increases the release of oxygen from hemoglobin, the oxygen-carrying protein contained within red blood cells.
# Employees: 111
Address: 11080 CIRCLEPOINT ROAD SUITE 200,WESTMINSTER,CO,USA